Bridgeway Capital Management’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Bridgeway Capital Management’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,924	Closed	-$57K	–	1298
2024 Q1	$57K	Sell	2,924 -2,000	-41%	-$35.6K	﹤0.01%	1259
2023 Q4	$88.6K	Sell	4,924 -2,000	-29%	-$30.8K	﹤0.01%	1257
2023 Q3	$125K	Hold	6,924	–	–	﹤0.01%	1185
2023 Q2	$436K	Hold	6,924	–	–	0.01%	939
2023 Q1	$344K	Hold	6,924	–	–	0.01%	975
2022 Q4	$199K	Hold	6,924	–	–	0.01%	1089
2022 Q3	$327K	Hold	6,924	–	–	0.01%	1011
2022 Q2	$299K	Sell	6,924 -400	-5%	-$18.3K	0.01%	996
2022 Q1	$403K	Hold	7,324	–	–	0.01%	996
2021 Q4	$555K	Sell	7,324 -4,000	-35%	-$314K	0.01%	952
2021 Q3	$1.02M	Buy	11,324 +3,000	+36%	+$321K	0.02%	820
2021 Q2	$1.05M	Buy	+8,324	New	+$1.13M	0.02%	839

Other funds holding DMRA

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Bridgeway Capital Management's DMRA Position: Q2 2024 in Review

Bridgeway Capital Management sold out of Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q2 2024, closing a stake of 2,924 shares — an estimated $57K sold.

Bridgeway Capital Management first reported a position in DMRA in Q2 2021 and held it in 12 quarters. The position peaked at $1.05M in Q2 2021. 22 funds tracked by Wall St. Rank hold DMRA as of Q2 2024.

Bridgeway Capital Management reported no remaining Damora Therapeutics, Inc. Ordinary Shares position as of Q2 2024 after selling out during the quarter.
Bridgeway Capital Management sold 2,924 Damora Therapeutics, Inc. Ordinary Shares shares in Q2 2024, an estimated $57K.
Bridgeway Capital Management first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q2 2021 and held it in 12 quarters.
Bridgeway Capital Management's Damora Therapeutics, Inc. Ordinary Shares position peaked at $1.05M in Q2 2021.
22 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q2 2024.

Based on Bridgeway Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.